Peptide record

TPDB66716

Anti-inflammatory Antidiabetic standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB66716
Anti-inflammatory Antidiabetic
Cardiometabolic peptides Immunity and inflammation peptides
AIPpred Peptipedia
standard
No
A 20-aa standard-residue multi-activity (Anti-inflammatory and Antidiabetic) peptide sequence curated from AIPpred and Peptipedia, with an available 3D structural model.
Sequence
AALGIGTDSVILIKCDERGK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C88H155N25O29S1
NQHMFPWY
GI
2059.41
6.41
3
3
8
-0
0.99
0.295
122.00
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
2
A
1
R
0
N
2
D
1
C
1
E
0
Q
3
G
0
H
3
I
2
L
2
K
0
M
0
F
0
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 2 C: 1 E: 1 Q: 0 G: 3 H: 0 I: 3 L: 2 K: 2 M: 0 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
20 reviewed residue count
C88H155N25O29S1 sequence-only estimate (linear, free termini)
2059.41 sequence-only estimate (linear, free termini)
6.41 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
0.99 sequence-only estimate (linear, free termini)
0.295 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA